Néstor Szerman

1.2k total citations
60 papers, 827 citations indexed

About

Néstor Szerman is a scholar working on Psychiatry and Mental health, Clinical Psychology and Epidemiology. According to data from OpenAlex, Néstor Szerman has authored 60 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 22 papers in Clinical Psychology and 20 papers in Epidemiology. Recurrent topics in Néstor Szerman's work include Substance Abuse Treatment and Outcomes (19 papers), Schizophrenia research and treatment (15 papers) and Attention Deficit Hyperactivity Disorder (12 papers). Néstor Szerman is often cited by papers focused on Substance Abuse Treatment and Outcomes (19 papers), Schizophrenia research and treatment (15 papers) and Attention Deficit Hyperactivity Disorder (12 papers). Néstor Szerman collaborates with scholars based in Spain, United States and Mexico. Néstor Szerman's co-authors include José Martı́nez-Raga, Pablo Vega, Ignacio Basurte-Villamor, F. Árias, M. Martínez, Carlos Roncero, Marta Torrens, Consuelo Morant, Enriqueta Ochoa Mangado and Miguel Casas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Translational Psychiatry and Frontiers in Psychiatry.

In The Last Decade

Néstor Szerman

56 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Néstor Szerman Spain 17 375 260 239 145 129 60 827
Laia Rodríguez-Cintas Spain 18 207 0.6× 219 0.8× 259 1.1× 105 0.7× 180 1.4× 41 745
Francisco González‐Sáiz Spain 17 226 0.6× 286 1.1× 197 0.8× 80 0.6× 176 1.4× 61 863
Fermín Fernández‐Calderón Spain 17 207 0.6× 326 1.3× 343 1.4× 71 0.5× 147 1.1× 80 883
Luca Rovai Italy 15 232 0.6× 147 0.6× 170 0.7× 72 0.5× 98 0.8× 37 522
Shamil Wanigaratne United Kingdom 15 201 0.5× 229 0.9× 168 0.7× 138 1.0× 94 0.7× 36 686
Glenys Dore Australia 14 260 0.7× 319 1.2× 277 1.2× 78 0.5× 155 1.2× 22 917
Elizabeth R. Disney United States 8 502 1.3× 211 0.8× 309 1.3× 51 0.4× 75 0.6× 9 920
Gerald F.X. Feeney Australia 21 382 1.0× 450 1.7× 453 1.9× 137 0.9× 184 1.4× 74 1.3k
Suzette Glasner‐Edwards United States 15 261 0.7× 358 1.4× 434 1.8× 167 1.2× 267 2.1× 21 1.2k
Angelo Giovanni Icro Maremmani Italy 22 500 1.3× 370 1.4× 416 1.7× 140 1.0× 230 1.8× 100 1.2k

Countries citing papers authored by Néstor Szerman

Since Specialization
Citations

This map shows the geographic impact of Néstor Szerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Néstor Szerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Néstor Szerman more than expected).

Fields of papers citing papers by Néstor Szerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Néstor Szerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Néstor Szerman. The network helps show where Néstor Szerman may publish in the future.

Co-authorship network of co-authors of Néstor Szerman

This figure shows the co-authorship network connecting the top 25 collaborators of Néstor Szerman. A scholar is included among the top collaborators of Néstor Szerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Néstor Szerman. Néstor Szerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roncero, Carlos, et al.. (2025). Is there a risk of esketamine misuse in clinical practice?. Therapeutic Advances in Drug Safety. 16. 1591762909–1591762909. 2 indexed citations
2.
Szerman, Néstor, et al.. (2024). Tobacco use disorder in patients with other mental disorders: a dual disorder perspective from clinical neuroscience. Frontiers in Psychiatry. 15. 1427561–1427561. 2 indexed citations
3.
Casas, Miguel, et al.. (2024). Tobacco use disorder and other mental disorders: The neglected dual disorder. PubMed. 18(2). 67–69. 2 indexed citations
4.
Basurte-Villamor, Ignacio, Pablo Vega, Carlos Roncero, et al.. (2022). A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment. Neuropsychiatric Disease and Treatment. Volume 18. 965–976. 4 indexed citations
5.
Szerman, Néstor, Ignacio Basurte-Villamor, Pablo Vega, et al.. (2022). Is there such a thing as gambling dual disorder? Preliminary evidence and clinical profiles. European Neuropsychopharmacology. 66. 78–91. 9 indexed citations
6.
Szerman, Néstor, F. Árias, Jaime Algorta, et al.. (2021). Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder.. PubMed. 49(4). 135–144. 1 indexed citations
7.
8.
Szerman, Néstor, Ignacio Basurte-Villamor, Pablo Vega, et al.. (2020). Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study. Drugs - Real World Outcomes. 7(1). 75–83. 23 indexed citations
9.
Szerman, Néstor, Francisco Ferre, Ignacio Basurte-Villamor, et al.. (2020). Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective. Frontiers in Psychiatry. 11. 589155–589155. 15 indexed citations
10.
Marín-Navarrete, Rodrigo, et al.. (2018). Latent Impulsivity Subtypes in Substance Use Disorders and Interactions with Internalizing and Externalizing Co-Occurring Disorders. Frontiers in Psychiatry. 9. 27–27. 6 indexed citations
11.
Roncero, Carlos, Lara Grau‐López, Carmen Barral, et al.. (2017). Relevant Differences in Perception and Knowledge of Professionals in Different Spanish Autonomous Communities Regarding Availability of Resources for Patients with Dual disorders.. PubMed. 44(1). 1–12. 2 indexed citations
12.
Roncero, Carlos, et al.. (2017). Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment. Frontiers in Psychiatry. 8. 173–173. 43 indexed citations
13.
Basurte-Villamor, Ignacio, et al.. (2016). Food addiction: a critical reflexion. Salud Mental. 39(3). 107–108. 1 indexed citations
14.
Roncero, Carlos, et al.. (2016). Professionals’ perception on the management of patients with dual disorders. Patient Preference and Adherence. Volume 10. 1855–1868. 16 indexed citations
15.
Roncero, Carlos, Pablo Vega, José Martı́nez-Raga, et al.. (2014). Professionals’ perceptions about healthcare resources for co-occuring disorders in Spain. International Journal of Mental Health Systems. 8(1). 35–35. 5 indexed citations
16.
Szerman, Néstor, Pablo Vega, Lara Grau‐López, et al.. (2014). Dual Diagnosis Resource Needs in Spain: A National Survey of Professionals. Journal of Dual Diagnosis. 10(2). 84–90. 16 indexed citations
17.
Sher, Leo, Zoltán Rihmer, José de León, et al.. (2014). Future Research and Clinical Directions in the Field of Men’s Mental Health: The Madrid Declaration. Frontiers in Public Health. 2. 242–242. 6 indexed citations
18.
Martı́nez-Raga, José, et al.. (2013). Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition. International Journal of Adolescent Medicine and Health. 25(3). 231–243. 23 indexed citations
19.
Martı́nez-Raga, José, et al.. (2012). Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder. CNS Drugs. 27(1). 15–30. 90 indexed citations
20.
Szerman, Néstor & Francisco J. Delgado. (1994). Diagnóstico dual, medicación y objetos transicionales en el abordaje psicoterapéutico de las drogodependencias. 6(1). 5–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laia Rodríguez-Cintas Breakdown of academic impact, for papers by Francisco González‐Sáiz Breakdown of academic impact, for papers by Fermín Fernández‐Calderón Breakdown of academic impact, for papers by Luca Rovai Breakdown of academic impact, for papers by Shamil Wanigaratne Breakdown of academic impact, for papers by Glenys Dore Breakdown of academic impact, for papers by Elizabeth R. Disney Breakdown of academic impact, for papers by Gerald F.X. Feeney Breakdown of academic impact, for papers by Suzette Glasner‐Edwards Breakdown of academic impact, for papers by Angelo Giovanni Icro Maremmani
Rankless by CCL
2026